Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1150 ARTÍCULOS , VIENDO DEL 241 AL 255

Modulating metals as a therapeutic strategy for Alzheimer's disease

Hung LW, Barnham KJ.

Future Med Chem. 2012 May;4(8):955-69. doi: 10.4155/fmc.12.32.

A comparative review of cell culture systems for the study of microglial biology in Alzheimer's disease

Stansley B, Post J, Hensley K.

J Neuroinflammation. 2012 May 31;9:115. doi: 10.1186/1742-2094-9-115.

Manipulation of microglial activity as a therapy for Alzheimer's disease

Tan B, Choi RH, Chin TJ, Kaur C, Ling EA.

Front Biosci (Schol Ed). 2012 Jun 1;4(4):1402-12. doi: 10.2741/s342.

Type 2 diabetes and/or its treatment leads to less cognitive impairment in Alzheimer's disease patients

Domínguez RO, Marschoff ER, González SE, Repetto MG, Serra JA.

Diabetes Res Clin Pract. 2012 Oct;98(1):68-74. doi: 10.1016/j.diabres.2012.05.013. Epub 2012 Jun 2.

Novel disease-modifying therapies for Alzheimer's disease

Jiang T, Yu JT, Tan L.

J Alzheimers Dis. 2012;31(3):475-92. doi: 10.3233/JAD-2012-120640.

Biochemistry of amyloid β-protein and amyloid deposits in Alzheimer disease

Masters CL, Selkoe DJ.

Cold Spring Harb Perspect Med. 2012 Jun;2(6):a006262. doi: 10.1101/cshperspect.a006262.

Proteolytic degradation of amyloid β-protein

Saido T, Leissring MA.

Cold Spring Harb Perspect Med. 2012 Jun;2(6):a006379. doi: 10.1101/cshperspect.a006379.

Novel chelators targeting cell cycle arrest, acetylcholinesterase, and monoamine oxidase for Alzheimer's therapy

Zheng H, Fridkin M, Youdim MB.

Curr Drug Targets. 2012 Jul;13(8):1089-106. doi: 10.2174/138945012802009026.

Alzheimer's disease, oestrogen and mitochondria: an ambiguous relationship

Grimm A, Lim YA, Mensah-Nyagan AG, Götz J, Eckert A.

Mol Neurobiol. 2012 Aug;46(1):151-60. doi: 10.1007/s12035-012-8281-x. Epub 2012 Jun 8.

Senile anorexia: three cases with complicated treatment and two occurrences of a Pisa syndrome

Schwerthöffer D, Fatke B, Bäuml J, Förstl H.

Int J Geriatr Psychiatry. 2012 Jul;27(7):765-8. doi: 10.1002/gps.2778.

Validity of the five-word test for the evaluation of verbal episodic memory and dementia in a memory clinic setting

Mormont E, Jamart J, Robaye L.

J Geriatr Psychiatry Neurol. 2012 Jun;25(2):78-84. doi: 10.1177/0891988712445088.

Pleiotropic protective effects of phytochemicals in Alzheimer's disease

Davinelli S, Sapere N, Zella D, Bracale R, Intrieri M, Scapagnini G.

Oxid Med Cell Longev. 2012;2012:386527. doi: 10.1155/2012/386527. Epub 2012 May 28.

TDP-43: a new player on the AD field?

Youmans KL, Wolozin B.

Exp Neurol. 2012 Sep;237(1):90-5. doi: 10.1016/j.expneurol.2012.05.018. Epub 2012 Jun 4.

Mitochondrial alterations, oxidative stress and neuroinflammation in Alzheimer's disease

Verri M, Pastoris O, Dossena M, Aquilani R, Guerriero F, Cuzzoni G, Venturini L, Ricevuti G, Bongiorno AI.

Int J Immunopathol Pharmacol. 2012 Apr-Jun;25(2):345-53. doi: 10.1177/039463201202500204.

The animal models of dementia and Alzheimer's disease for pre-clinical testing and clinical translation

Anand A, Banik A, Thakur K, Masters CL.

Curr Alzheimer Res. 2012 Nov;9(9):1010-29. doi: 10.2174/156720512803569055.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias